Human postmortem brain studies demonstrate that carriers of ANK3 alleles associated with BD have lower ANK3 expression at the transcript and protein levels12,13, suggesting that decreased expression of ANK3 contributes to disease. This evidence concerns the gene ANK3 and Behcet disease.